Publicaciones en colaboración con investigadores/as de Hospital do Meixoeiro (17)

2015

  1. Advanced glycation end-products as long-term predictors of death and reinfarction after an acute coronary syndrome

    Biomarkers in Medicine, Vol. 9, Núm. 3, pp. 209-216

2014

  1. A genome-wide association study on copy-number variation identifies a 11q11 loss as a candidate susceptibility variant for colorectal cancer

    Human Genetics, Vol. 133, Núm. 5, pp. 525-534

2013

  1. A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12

    BMC Genomics, Vol. 14, Núm. 1

  2. BMP2/BMP4 colorectal cancer susceptibility loci in northern and southern european populations

    Carcinogenesis, Vol. 34, Núm. 2, pp. 314-318

  3. Fluorescent Advanced Glycation End Products and Their Soluble Receptor: The Birth of New Plasmatic Biomarkers for Risk Stratification of Acute Coronary Syndrome

    PLoS ONE, Vol. 8, Núm. 9

  4. Statins modulate feedback regulation mechanisms between advanced glycation end-products and C-reactive protein: Evidence in patients with acute myocardial infarction

    European Journal of Pharmaceutical Sciences, Vol. 49, Núm. 4, pp. 512-518

2012

  1. Evidence for a role of advanced glycation end products in atrial fibrillation

    International Journal of Cardiology, Vol. 157, Núm. 3, pp. 397-402

  2. Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report

    Cardiovascular Diabetology, Vol. 11

2011

  1. Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of seattle heart failure score

    American Journal of Cardiology, Vol. 107, Núm. 6, pp. 938-944

2010

  1. Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels

    European Journal of Heart Failure, Vol. 12, Núm. 10, pp. 1092-1100

2007

  1. Tratamiento con factor VII activado tras hemorragia intensa por disección aórtica

    Farmacia Hospitalaria

2006

  1. Evaluación económica de la implantación por un equipo multidisciplinar de un protocolo de nutrición parenteral en pacientes tras resección intestinal

    Farmacia Hospitalaria, Vol. 30, Núm. 1, pp. 20-28

  2. Neurotoxicidad secundaria a ifosfamida consecutivamente en forma de psicosis y coma

    Farmacia Hospitalaria

2005

  1. Nutritional status study of inpatients in hospitals of Galicia

    European Journal of Clinical Nutrition, Vol. 59, Núm. 8, pp. 938-946

2002

  1. Detection of malnutrition risk in hospitalized elderly patients

    Nutrición hospitalaria : organo oficial de la Sociedad Española de Nutrición Parenteral y Enteral, Vol. 17, Núm. 1, pp. 22-27

  2. Estudio nutricional en pacientes geriátricos (mayores de 65 años) con nutrición enteral ambulatoria, correlación entre patología de base, aporte nutricional y tratamiento farmacológico

    Nutricion Hospitalaria, Vol. 17, Núm. 3, pp. 159-167

1997

  1. Analisis coste/efectividad de la implantacion de un programa de terapia secuencial con antibioticos

    Farmacia Hospitalaria, Vol. 21, Núm. 2, pp. 99-110